Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Intangibles: 2019-2020

Historic Change in Intangibles for Summit Therapeutics (SMMT) over the last 1 years, with Sep 2020 value amounting to -$168,000.

  • Summit Therapeutics' Change in Intangibles was N/A to -$168,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $25,000, marking a year-over-year change of. This contributed to the annual value of $136,000 for FY2019, which is N/A change from last year.
  • Per Summit Therapeutics' latest filing, its Change in Intangibles stood at -$168,000 for Q3 2020, which was down 4,300.00% from $4,000 recorded in Q2 2020.
  • Summit Therapeutics' Change in Intangibles' 5-year high stood at $164,000 during Q1 2020, with a 5-year trough of -$168,000 in Q3 2020.
  • For the 2-year period, Summit Therapeutics' Change in Intangibles averaged around $6,250, with its median value being $14,500 (2019).